OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
Ling-Hao Zhao, Xiao Liu, He–Xin Yan, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 278

Showing 1-25 of 278 citing articles:

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
Saranya Chidambaranathan Reghupaty, Paul B. Fisher, Devanand Sarkar
Advances in cancer research (2020), pp. 1-61
Open Access | Times Cited: 630

A global scientific strategy to cure hepatitis B
Peter Revill, Francis V. Chisari, Joan M. Block, et al.
˜The œLancet. Gastroenterology & hepatology (2019) Vol. 4, Iss. 7, pp. 545-558
Open Access | Times Cited: 420

HBV DNA Integration: Molecular Mechanisms and Clinical Implications
Thomas Tu, Magdalena A. Budzinska, Nicholas Shackel, et al.
Viruses (2017) Vol. 9, Iss. 4, pp. 75-75
Open Access | Times Cited: 346

The landscape of viral associations in human cancers
Marc Zapatka, Ivan Borozan, Daniel Brewer, et al.
Nature Genetics (2020) Vol. 52, Iss. 3, pp. 320-330
Open Access | Times Cited: 337

Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment
Paula García-Oliveira, Paz Otero, Antía G. Pereira, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 157-157
Open Access | Times Cited: 215

The role of telomeres and telomerase in cirrhosis and liver cancer
Jean–Charles Nault, Massih Ningarhari, Sandra Rebouissou, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 9, pp. 544-558
Closed Access | Times Cited: 194

Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Renumathy Dhanasekaran, Jean–Charles Nault, Lewis R. Roberts, et al.
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 492-509
Open Access | Times Cited: 178

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 170

Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma
Camille Péneau, Sandrine Imbeaud, Tiziana La Bella, et al.
Gut (2021) Vol. 71, Iss. 3, pp. 616-626
Open Access | Times Cited: 162

Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response
Stefano Caruso, Anna-Line Calatayud, Jill Pilet, et al.
Gastroenterology (2019) Vol. 157, Iss. 3, pp. 760-776
Open Access | Times Cited: 156

Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)
Grishma Hirode, Hannah Choi, Chien‐Hung Chen, et al.
Gastroenterology (2021) Vol. 162, Iss. 3, pp. 757-771.e4
Open Access | Times Cited: 131

KASL clinical practice guidelines for management of chronic hepatitis B

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 2, pp. 276-331
Open Access | Times Cited: 89

Chronic hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-positive patients
Won‐Mook Choi, Terry Cheuk‐Fung Yip, W. Ray Kim, et al.
Hepatology (2024) Vol. 80, Iss. 2, pp. 428-439
Open Access | Times Cited: 22

Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome
Fabien Zoulim, Pei‐Jer Chen, Maura Dandri, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 1087-1099
Open Access | Times Cited: 17

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma
Ping An, Jinghang Xu, Yanyan Yu, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 140

Immune suppression in chronic hepatitis B infection associated liver disease: A review
Tianyang Li, Yang Yang, Guo Zhou, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 27, pp. 3527-3537
Open Access | Times Cited: 133

Signaling pathways in hepatocellular carcinoma
Teresa García‐Lezana, Juan L López-Cánovas, Augusto Villanueva
Advances in cancer research (2020), pp. 63-101
Closed Access | Times Cited: 111

Adeno-associated virus in the liver: natural history and consequences in tumour development
Tiziana La Bella, Sandrine Imbeaud, Camille Péneau, et al.
Gut (2019) Vol. 69, Iss. 4, pp. 737-747
Open Access | Times Cited: 109

HBV induced hepatocellular carcinoma and related potential immunotherapy
Liyang Jia, Yanan Gao, Yaowu He, et al.
Pharmacological Research (2020) Vol. 159, pp. 104992-104992
Closed Access | Times Cited: 99

HBV-Integration Studies in the Clinic: Role in the Natural History of Infection
Teresa Pollicino, Giuseppe Caminiti
Viruses (2021) Vol. 13, Iss. 3, pp. 368-368
Open Access | Times Cited: 95

Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang, Xin Zhao, Xin–Rong Yang, et al.
Journal of Hepatology (2017) Vol. 67, Iss. 2, pp. 293-301
Closed Access | Times Cited: 92

Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
Thomas Tu, Henrik Zhang, Stephan Urban
Viruses (2021) Vol. 13, Iss. 2, pp. 180-180
Open Access | Times Cited: 63

Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao‐Chun Hsu, Vithika Suri, Mindie H. Nguyen, et al.
Gastroenterology (2022) Vol. 162, Iss. 4, pp. 1160-1170.e1
Closed Access | Times Cited: 54

Page 1 - Next Page

Scroll to top